Journals / Turkish archives of pediatrics (Online) / 2022 / Cilt: 57 - Sayı: 1

Clinical and Laboratory Features of Invasive Group A Streptococcal Infections: 8 Years Experience

Pages
75–80
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

It was found that 21 (42.9%) of the cases were hospitalized, and the median duration of hospitalization was 7 (IQR: 5-11) days.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Invasive infections caused by group A streptococci, including bacteremia, pneumonia, sepsis, necrotizing fasciitis, streptococcal toxic shock syndrome, and focal infections, are the significant causes of mortality and morbidity worldwide.
📊
Key Findings & Data:Materials and Methods: A descriptive observational study was conducted on children younger than 18 years with invasive group A streptococci infection in a single center between 2012 and 2019.
💡
Conclusion & Impact:It was found that 21 (42.9%) of the cases were hospitalized, and the median duration of hospitalization was 7 (IQR: 5-11) days.
🔬Design:Research Article
📍Scope:2012 Verileri
⚙️Variables:Domain Parameters

Özet

Objective: Invasive infections caused by group A streptococci, including bacteremia, pneumonia, sepsis, necrotizing fasciitis, streptococcal toxic shock syndrome, and focal infections, are the significant causes of mortality and morbidity worldwide. This study aimed to assess the clinical and laboratory features and management of children with invasive group A streptococci infections. Materials and Methods: A descriptive observational study was conducted on children younger than 18 years with invasive group A streptococci infection in a single center between 2012 and 2019. The clinical and laboratory features, treatment options, and patient outcomes were evaluated retrospectively. Results: Forty-nine patients diagnosed with an invasive group A streptococci infection were analyzed. Among them, 28 (57.1%) were boys and 21 (42.9%) were girls, with a median age of 84 months (IQR: 48-150). Group A streptococci strains were found to be isolated mainly from the skin and soft tissue abscesses (60.7%). It was found that 21 (42.9%) of the cases were hospitalized, and the median duration of hospitalization was 7 (IQR: 5-11) days. It was noted that all of the cases were treated, and infection-related mortality was not observed in any patient. Conclusions: For correct management of invasive group A streptococci infections, timely diagnosis, appropriate duration of antimicrobial therapy, and surgical intervention in selected cases are required. It is thought that examining this issue in future studies may provide clues regarding the localization, severity, management of the infection clinic, and treatment.

🔖

Cite This Article

ŞAHİN, A., ÖNCEL, E. K., AKSAY, A. K., ÇİFTDOĞAN, D. Y., YÜKSEL, N. C., YILMAZ, N. (2022). Clinical and Laboratory Features of Invasive Group A Streptococcal Infections: 8 Years Experience. Turkish archives of pediatrics (Online), Cilt: 57 - Sayı: 1, 75–80. https://ajindex.com/articles/418300

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (3)

  1. Feigin RD. Group A, group C, and group G β- hemolytic streptococcal infections. In: Feigin and Cherry’s Textbook of Pediatric Infectious Diseases. 8th ed. Philadelphia: Saunders/Elsevier; 2019:813-822
  2. Long SS, Prober CG, Fischer M. Streptococcus pyogenes (Group A streptococcus). In: Principles and Practice of Pediatric Infectious Diseases. 5th ed. Philadelphia: Elsevier; 2017:3596-3637
  3. Carapetis JR, Steer AC, Mulholland EK, Weber M. The global burden of group A streptococcal diseases. Lancet Infect Dis. 2005;5(11):685-694. [CrossRef] 4. Cannon JW, Zhung J, Bennett J, et al. The economic and health burdens of diseases caused by group A streptococcus in New Zealand. Int J Infect Dis. 2021;103:176-181. [CrossRef] 5. Dietrich ML, Steele RW. Group A streptococcus. Pediatr Rev. 2018;39(8):379-391. [CrossRef] 6. Stockmann C, Ampofo K, Hersh AL, et al. Evolving epidemiologic characteristics of invasive group A streptococcal disease in Utah, 2002-2010. Clin Infect Dis. 2012;55(4):479-487. [CrossRef] 7. Nelson GE, Pondo T, Toews KA, et al. Epidemiology of invasive group A streptococcal infections in the United States, 2005-2012. Clin Infect Dis. 2016;63(4):478-486. [CrossRef] 8. SteerAC, Lamagni T, Curtis N, Carapetis JR. Invasive group A streptococcal disease: epidemiology, pathogenesis and management. Drugs. 2012;72(9):1213-1227. [CrossRef] 9. Ciftçi E, Ince E, Bingöler EB, et al. Invasive group A streptococcal infections in children: an emerging infectious disease in Turkey. Ann Trop Paediatr. 2004;24(4):365-366. [CrossRef] 10. Leung TNH, Hon KL, Leung AKC. Group A streptococcus disease in Hong Kong children: an overview. Hong Kong Med J. 2018;24(6):593- 601. [CrossRef] 11. Maciá DE, Macián EMF, Borrás R, Gisbert SP, Bonet JIM. Streptococcus pyogenes infection in paediatrics: from pharyngotonsillitis o invasive infections. An Pediatr. 2018;88(2):75-81. [CrossRef] 12. McRae JE, Quinn HE, Saravanos GL, et al. Paediatric Active Enhanced Disease Surveillance (PAEDS) 2017 and 2018: prospective hospital-based surveillance for serious paediatric conditions. Commun Dis Intell (2018). 2020;44. [CrossRef] 13. Ahmed MI, Saunders RV, Bandi S. Group A streptococcal infections in children. Curr Pediatr Rev. 2021;17(1):70-73. [CrossRef] 14. Factor SH, Levine OS, Harrison LH, et al. Risk factors for pediatric invasive group A streptococcal disease. Emerg Infect Dis. 2005;11(7):1062-1066. [CrossRef] 15. Zachariadou L, Stathi A, Tassios PT, et al. Differences in the epi